312 studies found for:    Spasticity
Show Display Options
Rank Status Study
21 Terminated Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis
Condition: Muscle Spasticity
Intervention: Drug: tolperisone HCl
22 Active, not recruiting One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity
Conditions: Multiple Sclerosis;   Spasticity
Intervention: Drug: arbaclofen
23 Not yet recruiting Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis.
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex;   Drug: Placebo
24 Unknown  Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation
Conditions: Basal Energy Expenditure;   Spasticity
Intervention: Other: Weaning of Antispasticity Medication
25 Recruiting Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy
Condition: Lower Limb and Combined Lower Limb and Upper Limb Spasticity Due to Cerebral Palsy
Intervention: Drug: IncobotulinumtoxinA (16-20 Units per kg body weight)
26 Recruiting Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients
Conditions: Muscle Spasticity;   Multiple Sclerosis
Interventions: Biological: incabotulinumtoxinA;   Biological: Placebo
27 Completed Physiologic Studies of Spasticity
Conditions: Muscle Spasticity;   Healthy
28 Recruiting A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years
Condition: Cerebral Palsy
Interventions: Drug: Sativex;   Drug: Placebo
29 Completed Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity
Conditions: Muscle Spasticity;   Cerebrovascular Accident
Interventions: Drug: Botulinum toxin type A (Dysport®);   Other: Placebo
30 Completed Prevalence of Spasticity in Adults With Mental Retardation Living in the Community
Conditions: Mental Retardation;   Spasticity
31 Not yet recruiting Action of Baclofen Capsules in Spasticity Due to Multiple Sclerosis
Condition: Spasticity
Interventions: Drug: Baclofen dose 1;   Drug: Baclofen dose 2;   Drug: Placebo
32 Completed
Has Results
Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke Spasticity
Condition: Upper Limb Spasticity
Interventions: Drug: Botulinum toxin type A, BoNT-A;   Other: Rehabilitation Therapy
33 Completed
Has Results
A Multicenter, Open-label, Single Dose Study of the Safety and Efficacy of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Focal Upper Limb Spasticity
Condition: Spasticity, Post-Stroke
Intervention: Drug: Botulinum toxin type A
34 Completed Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity
Condition: Spasticity
Interventions: Drug: Botulinum toxin type A from laboratory Lanzhou;   Drug: Botulinum toxin type A from laboratory Allergan
35 Completed Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.
Conditions: Multiple Sclerosis;   Muscle Spasticity;   Spinal Cord Injury;   Stroke
Intervention: Drug: tizanidine hydrochloride capsule
36 Active, not recruiting Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke
Condition: Lower Limb Spasticity After Stroke
Interventions: Drug: A2NTX;   Drug: BOTOX
37 Unknown  Efficacy of Functional Electrical Stimulation (FES) in Persons Receiving Botulinum Neurotoxin for Upper Extremity Spasticity
Conditions: Upper Extremity Spasticity;   Stroke;   Acquired Brain Injury
Intervention: Device: Functional Electrical Stimulation (FES) through the Ness H200
38 Completed Effects on Quality of Life Following Dysport Treatment in Post-Stroke Spasticity of the Arm
Conditions: Cerebrovascular Accident;   Muscle Spasticity
Intervention: Drug: Botulinum type A toxin (Dysport)
39 Recruiting Long-term Surveillance of the MedStream Programmable Infusion System
Condition: Spasticity
Intervention: Device: MedStream Programmable Infusion System
40 Not yet recruiting ASIS for Botox in Upper Limb Spasticity
Conditions: Upper Limb Spasticity Unilaterally in Adults With History of Stroke;   Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors.
Interventions: Drug: Gadolinium;   Drug: Efficacy of Botox intramuscularly at Week 6;   Drug: Efficacy of Botox intramuscularly at Week 12,;   Drug: Efficacy of Botox intramuscularly at Week 18;   Drug: Efficacy of Botox intramuscularly at Week 24;   Drug: Efficacy of Botox intramuscularly at Week 30;   Drug: Efficacy of Botox subdermally at Week 6;   Drug: Efficacy of Botox subdermally at Week 12;   Drug: Efficacy of Botox subdermally at Week 18;   Drug: Efficacy of Botox subdermally at Week 24;   Drug: Efficacy of Botox subdermally at Week 30;   Drug: Adverse Reactions of Botox intramuscularly;   Drug: Adverse Reactions of Botox subdermally

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years